Todd W. Garner - 01 Mar 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Executive Vice President & CFO
Signature
Sarah M. Oliker for Todd W. Garner by Power of Attorney
Issuer symbol
CNMD
Transactions as of
01 Mar 2022
Transactions value $
-$67,794
Form type
4
Filing time
03 Mar 2022, 17:16:45 UTC
Previous filing
05 Jan 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +1,600 +1.17% $0 2,963 01 Mar 2022 Direct
transaction CNMD Common Stock Tax liability -$67,793 -469 -15.83% $144.55 2,494 01 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -1,600 -50% $0 1,600 01 Mar 2022 Common Stock 1,600 $0 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +55,000 $0 55,000 01 Mar 2022 Common Stock 55,000 $144.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period